Pyridostigmine Bromide (ALVOGEN INC.)


Welcome to the PulseAid listing for the Pyridostigmine Bromide drug offered from ALVOGEN INC.. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: ALVOGEN INC.
NON-PROPRIETARY NAME: Pyridostigmine Bromide
SUBSTANCE NAME: PYRIDOSTIGMINE BROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-06-29
END MARKETING DATE: 0000-00-00


Pyridostigmine Bromide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPyridostigmine Bromide from ALVOGEN INC.
LABELER NAME: ALVOGEN INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 180(mg/1)
START MARKETING DATE: 2015-06-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 47781-335_809df75c-e42a-2fd6-182c-03f8defe21dc
PRODUCT NDC: 47781-335
APPLICATION NUMBER: ANDA204737

Other PYRIDOSTIGMINE BROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ALVOGEN INC.Pyridostigmine Bromide
American Health PackagingPyridostigmine Bromide
Bryant Ranch Prepackpyridostigmine bromide
Cadila Healthcare Limitedpyridostigmine bromide
Impax GenericsPyridostigmine Bromide
KAISER FOUNDATION HOSPITALSPyridostigmine Bromide
Major Pharmaceuticalspyridostigmine bromide
Oceanside Pharmaceuticalspyridostigmine bromide
Sandoz IncRegonol
Valeant Pharmaceuticals North America LLCMestinon
Zydus Pharmaceuticals (USA) Inc.pyridostigmine bromide